Smoking Cessation in Workplaces in Hong Kong [Phase II]

NCT02659774 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 600

Last updated 2016-11-03

No results posted yet for this study

Summary

This study has the following objectives:

1. To examine the employers'/managerial staff's knowledge, attitudes and practices in promoting smoking cessation in workplace.
2. To evaluate the smoking behaviours of participants before and after attending a smoking cessation intervention.

Conditions

  • Smoking

Interventions

BEHAVIORAL

workshop (Motivational intervention)

Through intensive workshop which includes motivation of quitting enhancement, stress management, smoking triggers, cravings and relapse, to provide smoking cessation intervention

BEHAVIORAL

Health talk

Health talk provided information about hazards of tobacco (active smoking, second- and third-hand smoke), benefits of quitting smoking and methods to quit smoking

BEHAVIORAL

Face to Face counseling

Use motivational interview strategies through face-to-face counseling to provide smoking cessation intervention

BEHAVIORAL

Phone counseling

Use motivational interview strategies through telephone counseling to provide smoking cessation intervention

BEHAVIORAL

SMS

Use motivational interview strategies through telephone messages to provide smoking cessation intervention

BEHAVIORAL

Booklet

A 26-page booklet included information about smoking and diseases, benefits of quitting smoking, methods to quit smoking, how to handle withdrawal symptoms, stress management, declaration of quitting smoking, decisional balance of smoking or quitting

Sponsors & Collaborators

  • Lok Sin Tong Benevolent Society, Kowloon

    collaborator OTHER
  • The University of Hong Kong

    lead OTHER

Principal Investigators

  • Man-ping Wang, PhD · School of Nursing, The University of Hong Kong

Study Design

Allocation
NON_RANDOMIZED
Purpose
HEALTH_SERVICES_RESEARCH
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-01-31
Primary Completion
2017-06-30
Completion
2017-06-30

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02659774 on ClinicalTrials.gov